Chronic Pyelonephritis 

  • Author: James W Lohr, MD; Chief Editor: Vecihi Batuman, MD, FACP, FASN   more...
 
Updated: Dec 6, 2011
 

Background

Chronic pyelonephritis is characterized by renal inflammation and fibrosis induced by recurrent or persistent renal infection, vesicoureteral reflux, or other causes of urinary tract obstruction. The diagnosis of chronic pyelonephritis is made based on imaging studies such as ultrasound or CT scanning. It occurs almost exclusively in patients with major anatomic anomalies, most commonly in young children with vesicoureteral reflux (VUR).[1]

VUR is a congenital condition that results from incompetence of the ureterovesical valve due to a short intramural segment. VUR is present in 30-40% of young children with symptomatic UTIs and in almost all children with renal scars. It may also be acquired by patients with a flaccid bladder due to spinal cord injury. VUR is classified into 5 grades (I-V), according to the increasing degree of reflux. (See Treatment.) The diagnosis of VUR is frequently established based on radiologic evidence obtained during an evaluation for recurrent urinary tract infection (UTI) in young children.

Differential considerations

Analgesic abuse nephropathy, renal tuberculosis, renal dysplasia, xanthogranulomatous pyelonephritis, and renal malakoplakia may resemble chronic pyelonephritis. In malakoplakia, however, characteristic inclusions called Michaelis-Gutmann bodies are seen on biopsy.

Patient education

For patient education information, see Urinary Tract Infections (UTIs).

Next

Etiology and Pathophysiology

Chronic pyelonephritis is associated with progressive renal scarring, which can lead to end-stage renal disease (ESRD). For example, in reflux nephropathy, intrarenal reflux of infected urine is suggested to induce renal injury, which heals with scar formation.[2] In some cases, scars may form in utero in patients with renal dysplasia with perfusion defects. Infection without reflux is less likely to produce injury. Dysplasia may also be acquired from obstruction. Scars of high-pressure reflux can occur in persons of any age. In some cases, normal growth may lead to spontaneous cessation of reflux by age 6 years.

Factors that may affect the pathogenesis of chronic pyelonephritis are as follows: (1) the sex of the patient and his or her sexual activity; (2) pregnancy, which may lead to progression of renal injury with loss of renal function; (3) genetic factors; (4) bacterial virulence factors; and (5) neurogenic bladder dysfunction. In cases with obstruction, the kidney may become filled with abscess cavities (see Pyonephrosis).

Previous
Next

Epidemiology

In the United States, VUR may be present in 30-40% of children with UTIs. The prevalence rate of VUR in siblings of patients with chronic pyelonephritis is approximately 35%. VUR and chronic pyelonephritis are less common in African American children than in white children, with chronic pyelonephritis occurring 3 times more often in white children.[3] Chronic pyelonephritis is also twice as common in females as it is in males.

Chronic pyelonephritis occurs more often in infants and young children (younger than 2 y) than it does in older children and adults.

Previous
Next

Prognosis

The Birmingham Reflux Study clearly showed that medical and surgical management are equally effective in preventing renal damage from VUR.[4] Almost all children should receive a trial of medical management.

Although most children with chronic pyelonephritis due to VUR may experience spontaneous resolution of reflux, approximately 2% can still progress to renal failure, and 5-6% can have long-term complications, including hypertension.[5]

Hypertension contributes to the accelerated loss of renal function in persons with chronic pyelonephritis. Reflux nephropathy is the most common cause of hypertension in children, occurring in 10-20% of children with VUR and renal scars. The resolution of reflux does not appear to correct hypertension.

Complications of chronic pyelonephritis can also include the following:

  • Proteinuria
  • Focal glomerulosclerosis
  • Progressive renal scarring leading to end-stage renal disease[6]
  • Xanthogranulomatous pyelonephritis (XPN) - May occur in approximately 8.2% of cases and in 25% of patients with pyonephrosis; XPN can be confused with renal cancer[7, 8, 9, 10, 11]
  • Pyonephrosis - May occur in cases of obstruction
  • Progressive renal scarring (reflux nephropathy)
Previous
 
 
Contributor Information and Disclosures
Author

James W Lohr, MD  Professor, Department of Internal Medicine, Division of Nephrology, Fellowship Program Director, University of Buffalo State University of New York School of Medicine and Biomedical Sciences

James W Lohr, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Society of Nephrology, and Central Society for Clinical Research

Disclosure: Genzyme Honoraria Speaking and teaching

Coauthor(s)

Anupama Gowda, MBBS, MD  Consulting Staff, Atlanta Nephrology Associates, PC

Disclosure: Nothing to disclose.

Chike Magnus Nzerue, MD  Associate Dean for Clinical Affairs, Vice-Chairman of Internal Medicine, Meharry Medical College

Chike Magnus Nzerue, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Society of Nephrology, and National Kidney Foundation

Disclosure: Nothing to disclose.

Chief Editor

Vecihi Batuman, MD, FACP, FASN  Professor of Medicine, Section of Nephrology-Hypertension, Tulane University School of Medicine; Chief, Medicine Service, Southeast Louisiana Veterans Health Care System

Vecihi Batuman, MD, FACP, FASN is a member of the following medical societies: American College of Physicians, American Society of Hypertension, American Society of Nephrology, and International Society of Nephrology

Disclosure: Nothing to disclose.

Additional Contributors

Richard A Santucci, MD, FACS Specialist-in-Chief, Department of Urology, Detroit Medical Center; Chief of Urology, Detroit Receiving Hospital; Director, The Center for Urologic Reconstruction; Clinical Professor of Urology, Michigan State University College of Medicine

Richard A Santucci, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, and Société Internationale d'Urologie (International Society of Urology)

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References
  1. Guarino N, Casamassima MG, Tadini B, et al. Natural history of vesicoureteral reflux associated with kidney anomalies. Urology. Jun 2005;65(6):1208-11. [Medline].

  2. Dillon MJ, Goonasekera CD. Reflux nephropathy. J Am Soc Nephrol. Dec 1998;9(12):2377-83. [Medline].

  3. Chand DH; Rhoades T; Poe SA; Kraus S; Strife CF. Incidence and severity of vesicoureteral reflux in children related to age, gender, race and diagnosis. J Urol 2003 Oct [serial online]. 170(4 Pt 2):1548-50. Available at [Medline].

  4. Birmingham Reflux Study Group. Prospective trial of operative versus non-operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. Br Med J (Clin Res Ed). Jul 25 1987;295(6592):237-41. [Medline].

  5. Köhler J, Tencer J, Thysell H, et al. Vesicoureteral reflux diagnosed in adulthood. Incidence of urinary tract infections, hypertension, proteinuria, back pain and renal calculi. Nephrol Dial Transplant. Dec 1997;12(12):2580-7. [Medline].

  6. Zermann DH, Loffler U, Reichelt O, et al. Bladder dysfunction and end stage renal disease. Int Urol Nephrol. 2003;35(1):93-7. [Medline].

  7. Alan C, Ataus S, Tunc B. Xanthogranulamatous pyelonephritis with psoas abscess: 2 cases and review of the literature. Int Urol Nephrol. 2004;36(4):489-93. [Medline].

  8. Gonzalez Resina R, Barrero Candau R, Arguelles Salido E, et al. [Xanthogranulomatous pyelonephritis in childhood. A case report]. Actas Urol Esp. Jun 2005;29(6):596-8. [Medline].

  9. Oosterhof GO, Delaere KP. Xanthogranulomatous pyelonephritis. A review with 2 case reports. Urol Int. 1986;41(3):180-6. [Medline].

  10. Saavedra Jo S, Pow-Sang Godoy M, Benavente Corrales V, et al. [Xanthogranulomatous pyelonephritis: clinical, radiological and pathologic characteristics]. Arch Esp Urol. Jul-Aug 2004;57(6):595-600. [Medline].

  11. Zugor V, Amann K, Schrott KM, et al. [Xanthogranulomatous pyelonephritis: presentation of an unusual case]. Aktuelle Urol. Jun 2005;36(3):245-8. [Medline].

  12. Hiraoka M, Hori C, Tsukahara H, et al. Vesicoureteral reflux in male and female neonates as detected by voiding ultrasonography. Kidney Int. Apr 1999;55(4):1486-90. [Medline].

  13. Dracon M, Lemaitre L. [Urinary tract infection in adult. Leukocyturia]. Rev Prat. May 15 2003;53(10):1137-42. [Medline].

  14. Noe HN. The long-term results of prospective sibling reflux screening. J Urol. Nov 1992;148(5 Pt 2):1739-42. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.